Whey protein isolate is trading at around $12.30 per pound. Whey protein concentrate costs have more than doubled in two years. Some suppliers are sold out through the end of 2026. The price pressure is only just starting to reach retail shelves.
How we got here
Whey protein powder starts as liquid whey, a byproduct of hard cheese manufacturing. The raw milk supply isn't the problem; it's relatively stable. Processing infrastructure is the constraint. Converting liquid whey into the concentrated or isolated protein powder used in supplements and functional foods requires specialised filtration equipment and processing facilities that take years and significant capital to build. That's why supply can't simply catch up with demand overnight.
What did happen fast was demand. According to the International Food Information Council, 70% of US adults now say they actively try to consume protein, up from 59% in 2022. Innova Market Insights named "powerhouse protein" its top global food and beverage trend for 2026. This isn't a niche fitness story anymore.
GLP-1 medications like Ozempic and Wegovy added a new layer. According to RAND, around 12% of US adults have used a GLP-1 drug, with roughly half of those currently on an active prescription. Clinicians routinely recommend higher protein intake alongside these treatments to preserve muscle during weight loss. That has added millions of new protein consumers in a short window, many of whom aren't buying traditional supplement products. They're reaching for fortified foods, protein coffees, and ready-to-drink shakes.
Then the mainstream food industry moved in. In late 2025, Starbucks added Protein Lattes and Protein Cold Foams to its permanent US and Canada menu. In early 2026, PepsiCo launched a whey-based Propel Clear Protein powder and a Starbucks Coffee + Protein RTD. Billion-dollar food brands now compete for the same WPI supply that supplement companies built their businesses on.
The cost reality
Over two years, whey protein concentrate (WPC80) costs jumped 108%. Whey protein isolate (WPI) costs climbed roughly 139%. Standard whey powder prices are up more than 50% since January alone, according to DCA Market Intelligence, with isolate prices in the $12 range per the USDA.
These are ingredient costs. Retail price increases lag ingredient cost increases by 12 to 18 months, which means most consumers haven't felt the full impact yet. Brands are absorbing it now, or trying to. The margin pressure is real today. The consumer-facing price shock is largely still ahead.
The squeeze isn't limited to North America. European and Australian markets have reported substantial increases in whey concentrate pricing. Suppliers in several regions have locked inventory allocations months in advance. The global dairy trade is reorienting around whey values, with export-oriented producers in the US, Europe, and Oceania benefiting while manufacturers in importing markets face sharply higher input costs.
What it means for brands operating globally
Whether a brand is long-established in international markets or still building its footprint, the pressure lands differently depending on how supply relationships are structured. Brands with long-term supplier contracts and forward buying in place are partially insulated. Those sourcing on spot terms are now paying record prices with no certainty on volume. That split is widening the gap between brands that planned ahead and those that didn't.
For brands already operating across multiple markets, the challenge is margin consistency. Product pricing in Southeast Asia, the Middle East, or Europe is typically set against local competitive benchmarks, and those benchmarks were built on a cost structure that no longer exists. If input costs have nearly doubled since a brand's international pricing was last reviewed, the options are unappealing: raise retail prices and risk losing ground to local competitors who may have hedged better, hold prices and absorb the damage to margin, or reformulate to a lower-cost protein system and manage whatever brand perception risk that carries.
Supply reliability is a separate but related problem. International distribution, particularly through retail partners or distributors who hold inventory, depends on consistent product availability. Brands caught short on raw material allocations face delays, partial fulfilment, and the kind of gaps on shelf that take time to recover from. In markets where the brand is still building consumer loyalty, that inconsistency does lasting damage.
Smaller brands face the harder version of all of this. Without the purchasing volume to secure favourable long-term contracts, they're more exposed to spot pricing and allocation squeezes. The brands that built international operations assuming ingredient costs would stay stable are now doing the hardest repricing conversations.
Supply is expanding, but not yet
The industry is responding. In the US alone, announced capacity investments have reached $11 billion. Glanbia is adding 10 million pounds of WPI capacity through a joint venture in New Mexico. Ireland's Tirlán committed €126 million to premium whey production. Fonterra invested AUS$75 million in its Studholme powder plant in New Zealand. FrieslandCampina acquired Wisconsin Whey Protein and is expanding its WPI facility, with the project expected to add nearly 13 million pounds of annual capacity.
None of this is operational yet at scale. Most analysts put meaningful supply relief no earlier than late 2026, with full relief more likely through 2027. Prices probably won't return to 2023 and 2024 levels even then, given the permanent demand shift GLP-1 adoption has created.
The contract manufacturing problem
The shortage is hitting every brand, but not equally. The divide between brands with owned manufacturing and those relying on contract manufacturers is one of the sharpest fault lines in the current market.
Brands like Optimum Nutrition (owned by Glanbia, which is also one of the world's largest whey producers) sit at the vertically integrated end of the spectrum. Glanbia both produces the ingredient and manufactures the finished product, giving it direct control over supply allocation and cost. Dymatize, part of BellRing Brands, similarly manufactures in its own GMP-certified facilities and can absorb cost pressure across a larger operation. These brands aren't immune to higher ingredient costs, but they have levers that smaller brands simply don't have.
Brands relying on contract manufacturers face a compounded problem. The contract manufacturer is buying whey on the open market, or passing spot costs through to clients, and the brand owner often has limited visibility into how supply is being prioritised across the manufacturer's entire customer base. In a shortage, a contract manufacturer will protect its largest, most established clients first. A smaller brand sitting further down that priority list may face delayed production runs, reduced allocations, or being priced out entirely.
The question of whether a contract-reliant brand can survive this comes down to a few things: the strength of the relationship with the manufacturer, whether any supply has been forward-contracted, and how much margin the brand has to absorb cost increases before retail pricing becomes uncompetitive.
For brands in that position, the realistic options are to negotiate harder on allocation and pricing, explore blended protein formulations that reduce WPI dependence, or consider whether more direct ingredient sourcing relationships are worth building over a longer horizon. Some smaller brands have started working directly with ingredient suppliers to secure allocations outside the contract manufacturer's supply chain, though that requires the purchasing volume to make it viable.
What brands should be doing now
Forward contracts matter more than they did. Brands that secured supply at earlier prices are better positioned than those buying spot. If you don't have those relationships, building them should be the priority, not just for whey but for any high-demand functional ingredient.
Formulation flexibility is worth revisiting. Pea protein, egg white protein, and blended protein systems have all seen increased interest as brands manage both cost and supply risk. Consumer preference for whey remains strong, but having a strategy for blending or substitution in specific formats buys time and margin.
For any brand with international operations, ingredient cost volatility needs to be built into financial modelling now, not retrospectively. That means pricing reviews across existing markets, not just new ones. The brands that handle this period best will be the ones that treated it as a planning problem rather than waiting for the market to stabilise.
The shortage will ease. The investment being made across the industry will bring new supply online. But the structural demand shift is here to stay, and so is a higher price floor for quality whey. Planning around the old numbers is no longer an option.